Trials / Conditions / Hyperglycaemia (Diabetic)

Hyperglycaemia (Diabetic)

16 registered clinical trials studyying Hyperglycaemia (Diabetic) — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Validation of Remote Photoplethysmography for Non-Invasive Estimation of Blood Glucose and HbA1c NCT07502690	Tarumanagara University	—
Recruiting	Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes NCT07167693	David K Carroll	Phase 1 / Phase 2
Recruiting	Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant NCT06984822	Vastra Gotaland Region	N/A
Recruiting	Effect of Hyperglycaemia and Moxifloxacin on QTc Interval in T2DM NCT07014735	Richmond Pharmacology Limited	N/A
Completed	The SHINE Study: Safety of Implant and Preliminary Performance of the SHINE SYSTEM in Diabetic Subjects NCT05597605	Indigo Diabetes NV	N/A
Unknown	Perioperative Evaluation of Glucose Profile Using Continuous Glucose Monitoring System in Glucose Intolerant P NCT04343040	University Hospital, Lille	N/A
Completed	The Effect of Omega-3 FA on Glucose and Lipid Homeostasis Disorders in Obese/Diabetic Patients NCT03708887	Zhejiang University	N/A
Recruiting	Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD) NCT03087032	The First Affiliated Hospital of Xiamen University	Phase 4
Completed	Hypoglycaemia and Cardiac Arrhythmias in Type 1 Diabetes NCT04011683	Steno Diabetes Center Copenhagen	—
Completed	Peripheral Nerve Blocks for Above-the-knee Amputations NCT03404180	University of Florida	Phase 4
Completed	Investigating the Role of the Polyol Pathway in the Central Nervous System Production of Fructose NCT03469492	Yale University	EARLY_Phase 1
Completed	Multiple Ascending Doses of Globalagliatin Hydrochloride in Type 2 Diabetes Mellitus NCT03414892	Yabao Pharmaceutical Group	Phase 1
Completed	Development of Agents to Diminish the Risk of Hypoglycemia-induced Brain Injury in Type 1 Diabetes NCT03356457	Yale University	EARLY_Phase 1
Recruiting	Insulin Therapy for Postreperfusion Hyperglycemia NCT03152890	Seoul National University Hospital	Phase 4
Completed	The Assessment of Single-Dose Safety,Tolerability, Pharmacokinetics and Pharmacodynamic of Globalagliatin Hydr NCT03171623	Yabao Pharmaceutical Group	Phase 1
Completed	Microclinic Social Network Behavioral Health Trial in Jordan NCT01818674	Microclinic International	N/A